Dr. Forbes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
635 W 165th St
Box 92
New York, NY 10032Phone+1 212-305-9535- Is this information wrong?
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 1962 - 1963
- Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 1959 - 1961
- Icahn School of Medicine at Mount SinaiInternship, Transitional Year, 1957 - 1958
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1957
Certifications & Licensure
- NY State Medical License 1963 - 2021
- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Instrument for Glaucoma Early Detection and Monitoring Start of enrollment: 2008 Jan 01
Publications & Presentations
PubMed
- 8 citationsAssociations Between β-Peripapillary Atrophy and Reticular Pseudodrusen in Early Age-Related Macular DegenerationAakriti Garg, Dana M. Blumberg, Lama A. Al-Aswad, Maris Oll, Suzanne Yzer, Max Forbes, Rando Allikmets, Srilaxmi Bearelly> ;Investigative Ophthalmology & Visual Science. 2017 May 1
- 14 citationsIntravitreal recombinant human erythropoietin: a safety study in rabbits.Brian J. Song, Hui Cai, James C. Tsai, Stanley Chang, Max Forbes, Lucian V. Del Priore> ;Current Eye Research. 2008 Sep 1
- 25 citationsNovel electrophysiological instrument for rapid and objective assessment of magnocellular deficits associated with glaucoma.Vance Zemon, James C. Tsai, Max Forbes, Lama A. Al-Aswad, Chi-Ming Chen, James Gordon, Vivienne C. Greenstein, George Hu, Evy C. Strugstad, Elona Dhrami-Gavazi> ;Documenta Ophthalmologica. Advances in Ophthalmology. 2008 May 16
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: